Reevaluating the FDA's warning against the use of probiotics in preterm neonates: A societal statement by ESPGHAN and EFCNI
Authors:
- Chris H. P. van Den AkkerCAChris H. P. van Den Akker
- Nicholas D. EmbletonNENicholas D. Embleton
- Alexandre LapillonneAlexandre Lapillonne
- Walter A. MihatschWMWalter A. Mihatsch
- Silva SalvatoreSSSilva Salvatore
- Roberto B. CananiRCRoberto B. Canani
- Ener C. DinleyiciEDEner C. Dinleyici
- Magnus DomellöfMDMagnus Domellöf
- Alfredo GuarinoAGAlfredo Guarino
- Pedro Gutiérrez‐CastrellónPGPedro Gutiérrez‐Castrellón
- Iva HojsakIHIva Hojsak
- Flavia IndrioFlavia Indrio
Open Access
- 4 April 2024
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 78 (6) , 1403-1408
Abstract
The recent advisory issued by the United States Food and Drug Administration, cautioning against the routine administration of probiotics in preterm neonates, has sparked a lively debate within the scientific community. This commentary presents a perspective from members of the Special Interest Group on Gut Microbiota and Modifications within the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and other authors who contributed to the ESPGHAN position paper on probiotics for preterm infants, as well as representatives from the European Foundation for the Care of Newborn Infants. We advocate for a more nuanced and supportive approach to the use of certain probiotics in this vulnerable population, balancing the demonstrated benefits and risks.Keywords
This publication has 21 references indexed in Scilit:
- Probiotics, Prebiotics, Lactoferrin, and Combination Products for Prevention of Mortality and Morbidity in Preterm InfantsJAMA Pediatrics, 2023
- Probiotics in the Neonatal Intensive Care Unit—A Framework for Optimizing Product StandardsJAMA Pediatrics, 2023
- Association of Hospital Adoption of Probiotics With Outcomes Among Neonates With Very Low Birth WeightJAMA Health Forum, 2023
- Trends and Racial and Geographic Differences in Infant Mortality in the United States Due to Necrotizing Enterocolitis, 1999 to 2020JAMA Network Open, 2023
- Bifidobacterium bacteraemia is rare with routine probiotics use in preterm infants: A further case report with literature reviewAnaerobe, 2023
- Probiotics for prevention of necrotizing enterocolitis: Where do we stand?Seminars in Perinatology, 2022
- Probiotic sepsis in preterm neonates—a systematic reviewEuropean Journal of Pediatrics, 2022
- Live biotherapeutic products: the importance of a defined regulatory frameworkExperimental & Molecular Medicine, 2020
- The Unregulated Probiotic MarketClinical Gastroenterology and Hepatology, 2019
- Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics?Medecine Et Maladies Infectieuses, 2017